MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04332nam a22006977a 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
230628s20232023 xxu||||| |||| 00| 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
|---|
| International Standard Serial Number |
0090-3493 |
| 024 ## - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
00003246-990000000-00131 [pii] |
| 024 ## - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.1097/CCM.0000000000005861 [doi] |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
Ovid MEDLINE(R) |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
|---|
| PMID |
37010526 |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Cerebrovascular Complications of COVID-19 on Venovenous Extracorporeal Membrane Oxygenation. |
| 251 ## - Source |
|---|
| Source |
Critical Care Medicine. 51(8):1043-1053, 2023 Aug 01. |
| 252 ## - Abbreviated Source |
|---|
| Abbreviated source |
Crit Care Med. 51(8):1043-1053, 2023 Aug 01. |
| 253 ## - Journal Name |
|---|
| Journal name |
Critical care medicine |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Year |
2023 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Publication date |
2023 Aug 01 |
| 265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
|---|
| Publication status |
ppublish |
| 265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
|---|
| Medline status |
MEDLINE |
| 267 ## - Original year |
|---|
| Original year |
2023 |
| 268 ## - Previous citation |
|---|
| Original Source |
Critical Care Medicine. 2023 Apr 03 |
| 268 ## - Previous citation |
|---|
| -- |
2023-06-28 |
| 268 ## - Previous citation |
|---|
| Original abbreviated source |
Crit Care Med. 2023 Apr 03 |
| 268 ## - Previous citation |
|---|
| Original publication status |
aheadofprint |
| 268 ## - Previous citation |
|---|
| Original Medline status |
Publisher |
| 269 ## - Original dates |
|---|
| Original fiscal year |
FY2023 |
| 501 ## - WITH NOTE |
|---|
| Local holdings |
Available online from MWHC library: 1995 - present, Available in print through MWHC library: 1999 - 2006 |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
CONCLUSIONS: Our study highlights the association of obesity and pre-ECMO vasopressor use with the development of stroke in COVID-19 patients on venovenous ECMO. Also, the importance of relative decrease in Paco2 and moderate hyperoxia within 48 hours after ECMO initiation were additional risk factors. Copyright 2023 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
DESIGN: We analyzed prospectively collected observational data, using univariable and multivariable survival modeling to identify risk factors for stroke. Cox proportional hazards and Fine-Gray models were used, with death and discharge treated as competing risks. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
INTERVENTIONS: None. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
MEASUREMENTS AND MAIN RESULTS: Five hundred ninety-five patients (median age [interquartile range], 51 yr [42-59 yr]; male: 70.8%) had venovenous ECMO support. Forty-three patients (7.2%) suffered strokes, 83.7% of which were hemorrhagic. In multivariable survival analysis, obesity (adjusted hazard ratio [aHR], 2.19; 95% CI, 1.05-4.59) and use of vasopressors before ECMO (aHR, 2.37; 95% CI, 1.08-5.22) were associated with an increased risk of stroke. Forty-eight-hour post-ECMO Paco2-pre-ECMO Paco2/pre-ECMO Paco2 (relative DELTAPaco2) of negative 26% and 48-hour post-ECMO Pao2-pre-ECMO Pao2/pre-ECMO Pao2 (relative DELTAPao2) of positive 24% at 48 hours of ECMO initiation were observed in stroke patients in comparison to relative DELTAPaco2 of negative 17% and relative DELTAPao2 of positive 7% in the nonstroke group. Patients with acute stroke had a 79% in-hospital mortality compared with 45% mortality for stroke-free patients. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
OBJECTIVES: Evidence of cerebrovascular complications in COVID-19 requiring venovenous extracorporeal membrane oxygenation (ECMO) is limited. Our study aims to characterize the prevalence and risk factors of stroke secondary to COVID-19 in patients on venovenous ECMO. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
PATIENTS: Adult COVID-19 patients who were supported by venovenous ECMO. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
SETTING: Three hundred eighty institutions in 53 countries in the COVID-19 Critical Care Consortium (COVID Critical) registry. |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
English |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
*COVID-19 |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
*Extracorporeal Membrane Oxygenation |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
*Stroke |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Adult |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Carbon Dioxide |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
COVID-19/co [Complications] |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
COVID-19/ep [Epidemiology] |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
COVID-19/th [Therapy] |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Extracorporeal Membrane Oxygenation/ae [Adverse Effects] |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Female |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Humans |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Male |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Middle Aged |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Obesity |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Stroke/ep [Epidemiology] |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Stroke/et [Etiology] |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Indexing |
Automated |
| 651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
|---|
| Institution |
MedStar Washington Hospital Center |
| 656 ## - INDEX TERM--OCCUPATION |
|---|
| Department |
Surgery/Surgical Critical Care |
| 657 ## - INDEX TERM--FUNCTION |
|---|
| Medline publication type |
Journal Article |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Zaaqoq, Akram M |
| Institution Code |
MWHC |
| 790 ## - Authors |
|---|
| All authors |
Cho SM, Fanning JP, Fraser JF, Griffee MJ, Heinsar S, Jacobs JP, Kelly TL, Li Bassi G, Lorusso R, Mariani S, Peek GJ, Suen JY, White N, Zaaqoq AM |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| DOI |
<a href="https://dx.doi.org/10.1097/CCM.0000000000005861">https://dx.doi.org/10.1097/CCM.0000000000005861</a> |
| Public note |
https://dx.doi.org/10.1097/CCM.0000000000005861 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Journal Article |
| Item type description |
Article |
